A study to describe vascular and renal effects and safety of valsartan 80 and 160 mg in arterial hypertension patients

Trial Profile

A study to describe vascular and renal effects and safety of valsartan 80 and 160 mg in arterial hypertension patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2011

At a glance

  • Drugs Valsartan (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Sep 2008 Actual end date (Sep 2005) added as reported by ClinicalTrials.gov.
    • 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Aug 2008 Actual number of patients (120) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top